<table className="table">
  <caption><p>
    Glucocorticoid Stress Dosing Strategies in Patients at Risk for Adrenal Insufficiency</p>
  </caption>
  <thead>
    <tr>
      <th rowSpan="1" colSpan="1"><p>
        Patient Risk</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Patient Characteristics</p>
      </th>
      <th rowSpan="1" colSpan="1"><p>
        Glucocorticoid Management</p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        High risk</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Established primary or secondary adrenal insufficiency</p><p>
        Cushingoid features</p><p>
        Current equivalent of &gt;20 mg/d prednisone for &gt;3 wk</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Stress dosing</p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td rowSpan="1" colSpan="1"><p>
        Moderate or possible risk</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Past use equivalent of &gt;20 mg/d prednisone for &gt;3 wk in past year</p><p>
        Current or past equivalent of ≥5-20 mg/d prednisone for &gt;3 wk during past year</p><p>
        Long-term high-dose inhaled or topical glucocorticoid therapy</p><p>
        Recent intra-articular glucocorticoid therapy (≥3 injectable glucocorticoid treatments within 3 mo before surgery)</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Stress dosing or preoperative adrenal axis testing may be indicated</p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td rowSpan="1" colSpan="1"><p>
        Low risk</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        Equivalent of &lt;5 mg/d of prednisone for any duration</p><p>
        Any dose steroid for &lt;3 wk</p><p>
        Low-dose inhaled or topical glucocorticoid therapy</p>
      </td>
      <td rowSpan="1" colSpan="1"><p>
        No stress dosing</p>
      </td>
    </tr>
  </tbody>
</table>